Breaking News Instant updates and real-time market news.

CALM

Cal-Maine Foods

$40.95

0.6 (1.49%)

, HRL

Hormel Foods

$35.32

-0.54 (-1.51%)

04:55
11/29/16
11/29
04:55
11/29/16
04:55

Stephens to hold a field trip

Protein Plane Field Trip begins in Greeley, Colorado and winds up in New York on November 28-29.

CALM

Cal-Maine Foods

$40.95

0.6 (1.49%)

HRL

Hormel Foods

$35.32

-0.54 (-1.51%)

PPC

Pilgrim's Pride

$17.98

-0.2 (-1.10%)

SAFM

Sanderson Farms

$80.54

0.3 (0.37%)

  • 05

    Dec

  • 15

    Dec

CALM Cal-Maine Foods
$40.95

0.6 (1.49%)

11/10/16
GSCO
11/10/16
INITIATION
Target $37
GSCO
Neutral
Cal-Maine Foods initiated with a Neutral at Goldman
Goldman analyst Adam Samuelson initiated Cal-Mine with a Neutral and a $37 price target. The analyst said a near-term cyclical recovery is reflected in valuation.
06/16/16
06/16/16
UPGRADE

Hold
Cal-Maine Foods upgraded to Hold from Underweight at BB&T
BB&T analyst Brett Hundley upgraded Cal-Maine Foods to Hold citing limited downside to shares, reduced expectations, and checks that suggest that flock liquidations are intensifying due to current egg prices.
07/27/16
SPHN
07/27/16
NO CHANGE
Target $35
SPHN
Equal Weight
Cal-Maine Foods price target lowered to $35 from $45 at Stephens
Stephens analyst Farha Aslam remains cautious on Cal-Maine Foods, citing challenging egg industry fundamentals, including depressed demand. The analyst lowered the firm's price target on the stock to $35 from $45 and keeps an Equal Weight rating on shares.
05/24/16
05/24/16
NO CHANGE

Cal-Maine Foods estimates slashed at BB&T
BB&T cut Cal-Maine Foods estimates for the quarter to a loss of 14c from a profit of 32c and lowered full year estimates to $1.95 from $2.89 for 2017. The firm's analyst said recent price quotes show Southeast white large shell eggs down almost 70-% year-over-year.
HRL Hormel Foods
$35.32

-0.54 (-1.51%)

09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/16
OPCO
09/15/16
INITIATION
Target $38
OPCO
Perform
Hormel Foods initiated with a Perform at Oppenheimer
Oppenheimer analyst Rupesh Parikh initiated Hormel Foods with a Perform rating and $38 price target.
09/16/16
EDJN
09/16/16
UPGRADE
EDJN
Buy
Hormel Foods upgraded to Buy from Hold at Edward Jones
09/27/16
FBCO
09/27/16
NO CHANGE
Target $43
FBCO
Outperform
Hormel Foods added to US Focus List at Credit Suisse
Credit Suisse added Hormel Foods (HRL) to the US Focus List, replacing Kellogg (K). The firm Investment Policy Committee said analyst Rob Moskow's FY17 above consensus estimate reflects his view that the Street underestimates earnings momentum, is best positioned to capitalize on increased demand for convenient protein products and deflationary meat cost trends, higher margins from its mix to value-added products, and high short interest that will dissipate. Moskow rates Hormel an Outperform with a $43 price target.
PPC Pilgrim's Pride
$17.98

-0.2 (-1.10%)

11/18/16
JPMS
11/18/16
NO CHANGE
JPMS
Amid pricing controversy, JPMorgan would 'probably' own Tyson into earnings
Following yesterday's Washington Post story, JPMorgan analyst Ken Goldman says evidence continues to mount suggesting that the Georgia Dock pricing methodology could be flawed. It is still too early to draw full conclusions, but reporting on the topic suggests that if the price discovery methodology is changed, a chicken price decline is more likely than a price increase, Goldman tells investors in a research note. He points out that shares of Tyson Foods (TSN), Sanderson Farms (SAFM) and Pilgrim's Pride (PPC) all declined yesterday by at least 3%. The analyst sees some offsets, however, noting that companies seem to be selling some of their tray pack chicken at prices below Georgia Dock and that some companies no longer price off of the Dock. Goldman remains "highly constructive" on near-term fundamentals and notes that he'd "probably be long" shares of Tyson into Monday's earnings.
06/09/16
CLVD
06/09/16
NO CHANGE
CLVD
Pilgrim's Pride estimates lowered below consensus at Cleveland Research
Cleveland Research analyst Mike Piken lowered Pilgrim's Price estimates to reflect the volume impact of the shutdown of the Prepared Foods plant in Texas and to reflect the impact of potentially higher 2HF16 feed costs. Piken's Q2 earnings estimate goes to 60c, below consensus of 69c, and FY16 is lowered to $2.17, versus consensus of $2.11. The analyst has a Neutral rating on Pilgrim's Pride shares.
06/06/16
BMOC
06/06/16
DOWNGRADE
BMOC
Market Perform
Pilgrim's Pride downgraded on valuation, costs at BMO Capital
As noted earlier, BMO Capital downgraded Pilgrim's Pride to Market Perform from Outperform. The firm downgraded the stock based on valuation and rising feed costs. Target to $27 from $29.
06/06/16
BMOC
06/06/16
DOWNGRADE
BMOC
Market Perform
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
SAFM Sanderson Farms
$80.54

0.3 (0.37%)

08/18/16
LYON
08/18/16
UPGRADE
Target $113
LYON
Buy
Sanderson Farms upgraded to Buy from Outperform at CLSA
CLSA analyst Jeremy Scott upgraded Sanderson Farms to Buy saying the outlook for chicken margins has improved with U.S. corn and soybean crops set to break records on ideal growing conditions. The analyst raised his price target for the shares to $113 from $107.
10/05/16
DADA
10/05/16
INITIATION
Target $103
DADA
Neutral
Sanderson Farms initiated with a Neutral at DA Davidson
DA Davidson analyst Eric Gottlieb initiated Sanderson Farms with a Neutral and a $103 price target siting valuation.
06/07/16
JEFF
06/07/16
NO CHANGE
Target $70
JEFF
Buy
Jefferies recommends Tyson Foods following recent selloff
Jefferies analyst Akshay Jagdale attributes the recent selloff in protein stocks to the recent rally in grain prices and decline in pork margins. The analyst recommends buying shares of Tyson Foods (TSN) but continues to see "significant further potential downside" in Sanderson Farms (SAFM). Jagdale lowered his price target for Tyson to $70 and keeps a Buy rating on the name. He keeps a Hold rating on Hormel Foods (HRL) with a reduced price target of $34 and Underperform rating on Sanderson with a price target of $60.

TODAY'S FREE FLY STORIES

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary  »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

HII

Huntington Ingalls

$242.12

5.24 (2.21%)

17:21
01/19/18
01/19
17:21
01/19/18
17:21
Hot Stocks
Huntington Ingalls awarded $125.2M government contract modification »

Huntington Ingalls Inc. -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 21

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

, GD

General Dynamics

$209.10

1.3 (0.63%)

17:20
01/19/18
01/19
17:20
01/19/18
17:20
Hot Stocks
BAE Systems, General Dynamics awarded $237.6M government contract modification »

BAE Systems (BAESY) San…

BAESY

BAE Systems

$33.30

0.18 (0.54%)

GD

General Dynamics

$209.10

1.3 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SYRS

Syros Pharmaceuticals

$10.80

0.27 (2.56%)

17:17
01/19/18
01/19
17:17
01/19/18
17:17
Syndicate
Breaking Syndicate news story on Syros Pharmaceuticals »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$87.81

0.96 (1.11%)

17:13
01/19/18
01/19
17:13
01/19/18
17:13
Hot Stocks
Wintrust Financial raises its minimum wage to $15 per hour »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TWTR

Twitter

$23.66

-0.38 (-1.58%)

17:07
01/19/18
01/19
17:07
01/19/18
17:07
Hot Stocks
Twitter says has identified more IRA and automated Russia-based accounts »

In a statement on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ITEK

Inotek Pharmaceuticals

17:04
01/19/18
01/19
17:04
01/19/18
17:04
Hot Stocks
Boxer Capital reports 5.3% passive stake in Rocket Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIS

Oil States

$32.80

0.35 (1.08%)

17:03
01/19/18
01/19
17:03
01/19/18
17:03
Syndicate
Breaking Syndicate news story on Oil States »

Oil States files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

, QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

16:43
01/19/18
01/19
16:43
01/19/18
16:43
Hot Stocks
Broadcom receives second request from FTC for proposed Qualcomm deal »

Broadcom (AVGO) announced…

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRNC

tronc

$19.53

0.3 (1.56%)

16:37
01/19/18
01/19
16:37
01/19/18
16:37
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, WSJ says »

Ross Levinsohn, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AP

Ampco-Pittsburgh

$14.20

0.15 (1.07%)

16:35
01/19/18
01/19
16:35
01/19/18
16:35
Syndicate
Breaking Syndicate news story on Ampco-Pittsburgh »

Ampco-Pittsburgh files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

, UBSH

Union Bankshares

$38.79

0.54 (1.41%)

16:33
01/19/18
01/19
16:33
01/19/18
16:33
Hot Stocks
Carlyle Group reports 6% passive stake in Union Bankshares »

In a regulatory filing,…

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

UBSH

Union Bankshares

$38.79

0.54 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ANDX

Andeavor Logistics

$52.52

0.12 (0.23%)

16:31
01/19/18
01/19
16:31
01/19/18
16:31
Hot Stocks
Andeavor Logistics raises quarterly cash distribution to $1.00 per unit »

The fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

16:30
01/19/18
01/19
16:30
01/19/18
16:30
Options
Preliminary option volume of 22.8M today »

Preliminary option volume…

TRNC

tronc

$19.53

0.3 (1.56%)

16:26
01/19/18
01/19
16:26
01/19/18
16:26
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, DJ says »

Dow Jones added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$0.27

0.0285 (11.88%)

16:25
01/19/18
01/19
16:25
01/19/18
16:25
Conference/Events
Arcadia Biosciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.